# Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host

> **NCT00149032** · PHASE2 · WITHDRAWN · sponsor: **Hadassah Medical Organization** · enrollment: 50 (estimated)

## Conditions studied

- Hematological Malignancy
- Neoplasm Metastasis

## Interventions

- **PROCEDURE:** DLI sensitized against antigens expressed by the host.

## Key facts

- **NCT ID:** NCT00149032
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2001-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00149032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00149032, "Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00149032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*